Keith M. McGahan - 21 Jun 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role: Chief Legal Officer
Signature: /s/ Keith M. McGahan
Issuer symbol: N/A
Transactions as of: 21 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 23 Jun 2022, 21:13:58 UTC
Previous filing: 16 Mar 2022
Next filing: 05 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPPI	Common Stock, $0.001 par value	Award	$0	+246,085	+100%	$0.000000	491,025	21 Jun 2022	Direct	F1
holding	SPPI	Common Stock, $0.001 par value						6,250	21 Jun 2022	By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPPI	Stock Option (Right to Buy)	Award	$0	+904,077		$0.000000	904,077	21 Jun 2022	Common Stock	904,077	$0.6300	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit grant was approved by Spectrum Pharmaceuticals, Inc.'s ("Spectrum") board of directors on January 27, 2022, subject to stockholder approval of the Amended and Restated 2018 Long-Term Incentive Plan (the "Plan") under which the restricted stock unit was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
F2	The option grant was approved by Spectrum's board of directors on January 27, 2022, subject to stockholder approval of the Plan under which the option was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
F3	One third of the aggregate amount of option shares shall vest on each of January 27, 2023, 2024 and 2025, respectively.